Letter of Information and Consent to Participate in a Research Study
Study Title: Optimizing Decision-Making for Uterine Fibroid Surgery: Implementation of a multimedia patient decision aid for the management of uterine fibroids
Principal Investigator: Dr. Deborah Robertson, MD
Affiliation: St. Michael's Hospital, Unity Health Toronto — Department of Obstetrics and Gynecology
Conflict of Interest Statement
The principal investigator, co-investigators, and research staff do not have any conflicts of interest, financial or otherwise, related to this study or its outcome.
Introduction
You are being asked to participate in a research study because you have been referred for care related to uterine fibroids at Unity Health Toronto, and your care team believes you may be interested in using a new patient decision aid, MyFibroid Plan.
All research is voluntary — you do not have to participate, and you can withdraw at any time.
Before agreeing to take part in this study, it is important that you read the information in this research consent form. It includes details we think you need to know in order to decide if you wish to take part. If you have any questions, please contact the research team using the information at the end of this form.
You should be aware that it is possible that the Unity Health Toronto study investigator(s) will also be your treating doctor(s). Your treating doctor's role in this study is limited to introducing it to you; the research team, not your treating doctor, will explain the study in full and obtain your consent, and your treating doctor will not know whether you chose to participate. Your choice about whether to participate will not affect the medical care you receive.
Background and Purpose of the Research Study
Uterine fibroids are a common gynecologic condition and are the leading reason for hysterectomy surgery worldwide. People with fibroids often have several possible treatment options, and choosing between them can be difficult — the right choice often depends on your personal symptoms, values, and goals, such as whether you hope to become pregnant in the future. Feeling unsure or conflicted about this decision is common and has been linked to delays in treatment and dissatisfaction with care.
MyFibroid Plan is a web-based decision aid, developed with input from patients and physicians, to help people with fibroids understand their treatment options and make a choice that fits their needs. This study is an observational study comparing patients' experiences before and after the introduction of MyFibroid Plan into routine care; it does not involve being placed into different treatment groups by chance, and it is being conducted to understand how patients use the tool and whether it helps improve their experience of making this decision.
Participant Population and Study Enrollment
This study will enroll a maximum of 100 participants, recruited from St. Michael's Hospital and St. Joseph's Health Centre (Unity Health Toronto) combined.
Study Duration
Overall, this study is expected to run for about six months (June to November 2026). Your involvement in this study will last for about one survey session (approximately 10 minutes); however, you may be contacted up to two additional times over a two-week period if you have not yet completed the survey.
Description of Research Activities
Changes to Standard Care
The care that you receive for your condition will not be changed if you decide to participate in this study. All research interventions and activities will be in addition to the usual care.
- Accessing the Decision Aid: You will use the web-based decision aid to learn about treatment options for uterine fibroids.
- Tracking Your Participation: To monitor completion rates while keeping your answers anonymous, you will be asked to enter a unique Study ID at the start of the survey. This ID was provided to you by the research team.
- Follow-up: If the survey is not completed within two weeks, the research team may contact you via Epic MyChart message or telephone, up to two times, to provide assistance or reminders.
Research Questionnaires and Surveys
A survey is embedded within the decision aid to capture your feedback. It includes questions about: your background and how fibroids affect your life; your experience using the MyFibroid Plan tool; how sure you feel about your treatment choice; and your experience working with your doctor. It will take approximately 10 minutes to complete.
The survey is administered electronically through a secure link (REDCap) embedded within the decision aid. You may complete it on a device of your choosing (phone, tablet, or computer), at a time and place that works for you.
You can skip questions that you do not wish to answer. If you have any questions or concerns while answering these questions, please talk to an investigator or research team member.
Potential Risks
There are no physical risks. Some questions may cause mild emotional discomfort when reflecting on your health experiences. If this happens, you can skip the question, pause, or stop your participation at any time. The study team is available to discuss any concerns.
Potential Benefits
There are no direct medical benefits to you. However, your feedback is helpful for optimizing the tool for future patients.
Alternatives to Participation
This study is not researching ways to provide you with medical treatment for your fibroids, so the alternative to taking part in this study is to not take part. Whether you choose to take part in this study or not, you will receive the same standard and level of care at Unity Health Toronto, and you may discuss your treatment options with your doctor at any time, with or without using the MyFibroid Plan decision aid.
Privacy and Confidentiality of Your Personally Identifying Information and Study Data
This section describes how your personally identifying information and study data will be accessed, disclosed, and stored during this study. All persons involved in the study are committed to respecting your privacy. Other than the individuals or groups described in this section, no persons will have access to your personally identifying information without your consent, unless required by law.
Personally identifying information is any information that could be used to identify you; this includes your name and address. Study data is information that is generated by and/or collected for a study that has been stripped of personally identifying information.
Protecting Your Privacy
The study team will make every effort to keep your personally identifying information private and confidential in accordance with all applicable privacy legislation, including the Personal Health Information Protection Act (PHIPA) of Ontario.
No personally identifying information will be allowed off site in any form, unless required by law or as described in this consent form.
All data collected for research purposes will be labelled with a unique study identification number (Study ID) instead of any of your personally identifying information. The principal investigator (based at St. Michael's Hospital, Unity Health Toronto) is in control of the Master Linking Log that links your Study ID to you personally, and will keep it stored separately from the study data.
By proceeding with this study, you are authorizing access to your medical records by representatives of the Unity Health Toronto Research Ethics Board. Such access will only be used to verify the authenticity and accuracy of the information collected for this study, without violating your confidentiality, to the extent permitted by applicable laws and regulations.
Online Surveys, Third Party Websites, and Web Based Apps
This study uses REDCap (Research Electronic Data Capture), a secure, web-based survey platform, to administer the study survey found at the end of the decision aid tool. REDCap is hosted on secure servers through AHRC, Unity Health Toronto.
No directly identifying information (such as your name, email address, or IP address) is collected by REDCap. You are identified within the survey only by your unique Study ID.
Storage and Retention of Your Personally Identifying Information and Study Data
Personally Identifying Information Storage and Retention
All personally identifying data used in this study will be securely stored. No paper copies of identifiable participant information are collected or stored for this study. Electronic copies (i.e., the Master Linking Log) are stored in a password-protected file on a secure Unity Health Toronto hospital server, accessible only to approved members of the research team.
In accordance with Unity Health Toronto policy, this information will be retained for five years following publication of study results and then securely destroyed.
Study Data Storage and Retention
Your de-identified survey responses (study data) will be securely stored electronically, separately from the Master Linking Log, in a password-protected file on a secure Unity Health Toronto hospital server. Access to study data is strictly restricted to approved members of the research team. In accordance with Unity Health Toronto policy, study data will be retained for five years following publication of study results and then securely destroyed.
Study Results and Study Registration
The results of this study may be presented at a scientific conference or published in a scientific journal.
Some scientific journals may require us to make the study data available to the journal, its reviewers, or to other researchers.
You will never be personally identified in any publication, report, or presentation that may come from this study.
Potential Costs and Reimbursement
There are no costs to you for participation in this study. You will not be paid for your participation in this study.
Participation and Withdrawal
Participation in this Study
Your participation in this study is completely voluntary. If you choose not to participate, there will be no impact to the medical care you receive at, or your relationship with, Unity Health Toronto, now or in the future, for you or your family.
Implied Consent: This study uses an implied consent process. By proceeding to the decision aid and submitting the survey, after having read this information, you are providing your consent to participate in this research.
Withdrawal from this Study
If you choose to take part in this study, you can change your mind without giving a reason, and you may withdraw from this study at any time without any effect on the medical care you or your family receive at Unity Health Toronto. You may stop using the decision aid or exit the survey at any time. If at any time you choose to withdraw from this study, please contact a member of the study team using the information below.
Data Usage: Only fully completed surveys will be used for the primary study analysis. If you exit the survey before clicking "submit," your incomplete answers will not be included in the research results and will be withdrawn from the study.
New Information About this Study
We may make changes to this study as it progresses, such as updates to the decision aid content or survey. We do not anticipate that any such changes would affect your decision to participate; however, if this changes, we will notify you in a timely manner.
Research Ethics Board Contact
If you have any questions regarding your rights as a research participant, you may contact the Unity Health Toronto Research Ethics Board Office at 416-864-6060 ext. 42557, during business hours (9:00 a.m. to 5:00 p.m.).
Study Contacts
If at any time during the study you have questions about the study or the study activities, you should contact the study team at 416-867-7460 ext.48119, during business hours or by email at myfibroidplan@gmail.com.
By clicking "Begin," you acknowledge that you have read this information and agree to participate in this study.